Literature DB >> 20890651

Case report of the rare deletion at codon 69 of reverse transcriptase in a South African HIV-1 subtype C infected patient.

Carole L Wallis1, Willem D F Venter, Wendy S Stevens, Maria A Papathanasopoulos.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20890651     DOI: 10.1007/s11262-010-0533-0

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


× No keyword cloud information.
  13 in total

1.  Genotypic and phenotypic resistance patterns of human immunodeficiency virus type 1 variants with insertions or deletions in the reverse transcriptase (RT): multicenter study of patients treated with RT inhibitors.

Authors:  B Masquelier; E Race; C Tamalet; D Descamps; J Izopet; C Buffet-Janvresse; A Ruffault; A S Mohammed; J Cottalorda; A Schmuck; V Calvez; E Dam; H Fleury; F Brun-Vézinet
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

2.  Analysis of RT sequences of subtype C HIV-type 1 isolates from indian patients at failure of a first-line treatment according to clinical and/or immunological WHO guidelines.

Authors:  Alaka Deshpande; Anne Cécile Jeannot; Marie Hélène Schrive; Linda Wittkop; Patricia Pinson; Hervé J Fleury
Journal:  AIDS Res Hum Retroviruses       Date:  2010-03       Impact factor: 2.205

3.  Novel deletion of HIV type 1 reverse transcriptase residue 69 conferring selective high-level resistance to nevirapine.

Authors:  K Suzuki; G R Kaufmann; M Mukaide; P Cunningham; C Harris; L Leas; M Kondo; M Imai; S L Pett; R Finlayson; J Zaunders; A Kelleher; D A Cooper
Journal:  AIDS Res Hum Retroviruses       Date:  2001-09-01       Impact factor: 2.205

4.  Evidence of a role for the Q151L mutation and the viral background in development of multiple dideoxynucleoside-resistant human immunodeficiency virus type 1.

Authors:  J G García-Lerma; P J Gerrish; A C Wright; S H Qari; W Heneine
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

5.  Relative fitness and replication capacity of a multinucleoside analogue-resistant clinical human immunodeficiency virus type 1 isolate with a deletion of codon 69 in the reverse transcriptase coding region.

Authors:  Cristina Villena; Julia G Prado; Maria Carmen Puertas; Miguel Angel Martínez; Bonaventura Clotet; Lidia Ruiz; Neil T Parkin; Luis Menéndez-Arias; Javier Martinez-Picado
Journal:  J Virol       Date:  2007-02-21       Impact factor: 5.103

6.  Unusual codon 69 insertions: influence on human immunodeficiency virus type 1 reverse transcriptase drug susceptibility.

Authors:  Elisabetta Bulgheroni; Francesco Croce; Paola Citterio; Ottavia Viganò; Raffaella Visonà; Eugenio Sala; Massimo Galli; Stefano Rusconi
Journal:  J Clin Virol       Date:  2004-01       Impact factor: 3.168

7.  HIV type-1 clade C resistance genotypes in treatment-naive patients and after first virological failure in a large community antiretroviral therapy programme.

Authors:  Catherine Orrell; Rochelle P Walensky; Elena Losina; Jennifer Pitt; Kenneth A Freedberg; Robin Wood
Journal:  Antivir Ther       Date:  2009

8.  Prevalence of HIV-1 drug resistance after failure of a first highly active antiretroviral therapy regimen in KwaZulu Natal, South Africa.

Authors:  Vincent C Marconi; Henry Sunpath; Zhigang Lu; Michelle Gordon; Kofi Koranteng-Apeagyei; Jane Hampton; Steve Carpenter; Janet Giddy; Douglas Ross; Helga Holst; Elena Losina; Bruce D Walker; Daniel R Kuritzkes
Journal:  Clin Infect Dis       Date:  2008-05-15       Impact factor: 9.079

9.  Varied patterns of HIV-1 drug resistance on failing first-line antiretroviral therapy in South Africa.

Authors:  Carole L Wallis; John W Mellors; Willem D F Venter; Ian Sanne; Wendy Stevens
Journal:  J Acquir Immune Defic Syndr       Date:  2010-04-01       Impact factor: 3.731

10.  The public health approach to identify antiretroviral therapy failure: high-level nucleoside reverse transcriptase inhibitor resistance among Malawians failing first-line antiretroviral therapy.

Authors:  Mina C Hosseinipour; Joep J G van Oosterhout; Ralf Weigel; Sam Phiri; Debbie Kamwendo; Neil Parkin; Susan A Fiscus; Julie A E Nelson; Joseph J Eron; Johnstone Kumwenda
Journal:  AIDS       Date:  2009-06-01       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.